APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allergy Immunotherapies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

Selected research

Market Analysis & Forecast

Global Allergy Immunotherapies Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchAllergy Immunotherapies Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergy Immunotherapies Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergy Immunotherapies Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergy Immunotherapies Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.

Read the full market overview

Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.

In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.

Report Includes

This report presents an overview of global market for Allergy Immunotherapies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Allergy Immunotherapies, also provides the revenue of main regions and countries. Of the upcoming market potential for Allergy Immunotherapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Allergy Immunotherapies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Allergy Immunotherapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Allergy Immunotherapies revenue, projected growth trends, production technology, application and end-user industry.

Allergy Immunotherapies Segment by Company

ALK

Stallergenes

HAL

Allergy Immunotherapies Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Immunotherapies Segment by Application

Allergic Rhinitis

Allergic Asthma

Other

Allergy Immunotherapies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Allergy Immunotherapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Allergy Immunotherapies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapies revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Subcutaneous Immunotherapy Major Player Table 3. Sublingual Immunotherapy Major Player Table 4. Global Allergy Immunotherapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Allergic Rhinitis Major Player Table 6. Allergic Asthma Major Player Table 7. Other Major Player Table 8. Allergy Immunotherapies Industry Trends Table 9. Allergy Immunotherapies Industry Drivers Table 10. Allergy Immunotherapies Industry Opportunities and Challenges Table 11. Allergy Immunotherapies Industry Restraints Table 12. Global Allergy Immunotherapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Allergy Immunotherapies Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Allergy Immunotherapies Market Share by Region (2021-2026) Table 15. Global Allergy Immunotherapies Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Allergy Immunotherapies Market Share by Region (2027-2032) Table 17. Global Allergy Immunotherapies Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Allergy Immunotherapies Revenue Market Share by Players (2021-2026) Table 19. Global Allergy Immunotherapies Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Allergy Immunotherapies Key Players Headquarters & Area Served Table 21. Global Allergy Immunotherapies Players, Product Type & Application Table 22. Global Allergy Immunotherapies Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Allergy Immunotherapies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Allergy Immunotherapies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Allergy Immunotherapies Revenue Market Share by Type (2021-2026) Table 29. Global Allergy Immunotherapies Revenue Market Share by Type (2027-2032) Table 30. Global Allergy Immunotherapies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Allergy Immunotherapies Revenue Market Share by Application (2021-2026) Table 34. Global Allergy Immunotherapies Revenue Market Share by Application (2027-2032) Table 35. ALK Company Information Table 36. ALK Business Overview Table 37. ALK Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ALK Allergy Immunotherapies Product Portfolio Table 39. ALK Recent Development Table 40. Stallergenes Company Information Table 41. Stallergenes Business Overview Table 42. Stallergenes Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Stallergenes Allergy Immunotherapies Product Portfolio Table 44. Stallergenes Recent Development Table 45. HAL Company Information Table 46. HAL Business Overview Table 47. HAL Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. HAL Allergy Immunotherapies Product Portfolio Table 49. HAL Recent Development Table 50. North America Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 51. North America Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 52. North America Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 53. North America Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 54. North America Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 55. North America Allergy Immunotherapies Revenue by Country (2021-2026) & (US$ Million) Table 56. North America Allergy Immunotherapies Revenue by Country (US$ Million) & (2027-2032) Table 57. Europe Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 58. Europe Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 59. Europe Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 60. Europe Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 61. Europe Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 62. Europe Allergy Immunotherapies Revenue by Country (2021-2026) & (US$ Million) Table 63. Europe Allergy Immunotherapies Revenue by Country (US$ Million) & (2027-2032) Table 64. China Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 65. China Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 66. China Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 67. China Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 68. Asia Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 69. Asia Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 70. Asia Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 71. Asia Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 72. Asia Allergy Immunotherapies Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Asia Allergy Immunotherapies Revenue by Region (US$ Million) & (2021-2026) Table 74. Asia Allergy Immunotherapies Revenue by Region (US$ Million) & (2027-2032) Table 75. SAMEA Allergy Immunotherapies Revenue by Type (2021-2026) & (US$ Million) Table 76. SAMEA Allergy Immunotherapies Revenue by Type (2027-2032) & (US$ Million) Table 77. SAMEA Allergy Immunotherapies Revenue by Application (2021-2026) & (US$ Million) Table 78. SAMEA Allergy Immunotherapies Revenue by Application (2027-2032) & (US$ Million) Table 79. SAMEA Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. SAMEA Allergy Immunotherapies Revenue by Country (2021-2026) & (US$ Million) Table 81. SAMEA Allergy Immunotherapies Revenue by Country (US$ Million) & (2027-2032) Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Allergy Immunotherapies Image Figure 2. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergy Immunotherapies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Subcutaneous Immunotherapy Image Figure 5. Sublingual Immunotherapy Image Figure 6. Global Allergy Immunotherapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Allergy Immunotherapies Market Size Share 2021 VS 2025 VS 2032 Figure 8. Allergic Rhinitis Image Figure 9. Allergic Asthma Image Figure 10. Other Image Figure 11. Global Allergy Immunotherapies Market Size (US$ Million) & (2021-2032) Figure 12. Global Allergy Immunotherapies Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Allergy Immunotherapies Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Allergy Immunotherapies Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Allergy Immunotherapies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Allergy Immunotherapies Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Allergy Immunotherapies Revenue Market Share by Type (2021-2032) Figure 19. Global Allergy Immunotherapies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Allergy Immunotherapies Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Allergy Immunotherapies Revenue Market Share by Application (2021-2032) Figure 22. North America Allergy Immunotherapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Allergy Immunotherapies Revenue Share by Type (2021-2032) Figure 24. North America Allergy Immunotherapies Revenue Share by Application (2021-2032) Figure 25. North America Allergy Immunotherapies Revenue Share by Country (2021-2032) Figure 26. United States Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Allergy Immunotherapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Allergy Immunotherapies Revenue Share by Type (2021-2032) Figure 31. Europe Allergy Immunotherapies Revenue Share by Application (2021-2032) Figure 32. Europe Allergy Immunotherapies Revenue Share by Country (2021-2032) Figure 33. Germany Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Allergy Immunotherapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Allergy Immunotherapies Revenue Share by Type (2021-2032) Figure 43. China Allergy Immunotherapies Revenue Share by Application (2021-2032) Figure 44. Asia Allergy Immunotherapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Allergy Immunotherapies Revenue Share by Type (2021-2032) Figure 46. Asia Allergy Immunotherapies Revenue Share by Application (2021-2032) Figure 47. Asia Allergy Immunotherapies Revenue Share by Region (2021-2032) Figure 48. Japan Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Allergy Immunotherapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Allergy Immunotherapies Revenue Share by Type (2021-2032) Figure 56. SAMEA Allergy Immunotherapies Revenue Share by Application (2021-2032) Figure 57. SAMEA Allergy Immunotherapies Revenue Share by Country (2021-2032) Figure 58. Brazil Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Allergy Immunotherapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Companies covered
  • ALK
  • Stallergenes
  • HAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Allergy Immunotherapies Market by Type
  3. 1.2.1 Global Allergy Immunotherapies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Immunotherapy
  5. 1.2.3 Sublingual Immunotherapy
  6. 1.3 Allergy Immunotherapies Market by Application
  7. 1.3.1 Global Allergy Immunotherapies Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Allergic Rhinitis
  9. 1.3.3 Allergic Asthma
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Allergy Immunotherapies Market Dynamics
  1. 2.1 Allergy Immunotherapies Industry Trends
  2. 2.2 Allergy Immunotherapies Industry Drivers
  3. 2.3 Allergy Immunotherapies Industry Opportunities and Challenges
  4. 2.4 Allergy Immunotherapies Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Allergy Immunotherapies Market Perspective (2021-2032)
  2. 3.2 Global Allergy Immunotherapies Growth Trends by Region
  3. 3.2.1 Global Allergy Immunotherapies Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Allergy Immunotherapies Market Size by Region (2021-2026)
  5. 3.2.3 Global Allergy Immunotherapies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Allergy Immunotherapies Revenue by Players
  2. 4.1.1 Global Allergy Immunotherapies Revenue by Players (2021-2026)
  3. 4.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Allergy Immunotherapies Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Allergy Immunotherapies Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Allergy Immunotherapies Key Players Headquarters & Area Served
  7. 4.4 Global Allergy Immunotherapies Players, Product Type & Application
  8. 4.5 Global Allergy Immunotherapies Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Allergy Immunotherapies Market CR5 and HHI
  11. 4.6.3 2025 Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
5 Allergy Immunotherapies Market Size by Type
  1. 5.1 Global Allergy Immunotherapies Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 5.3 Global Allergy Immunotherapies Revenue Market Share by Type (2021-2032)
6 Allergy Immunotherapies Market Size by Application
  1. 6.1 Global Allergy Immunotherapies Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Allergy Immunotherapies Revenue by Application (2021-2032)
  3. 6.3 Global Allergy Immunotherapies Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ALK
  2. 7.1.1 ALK Company Information
  3. 7.1.2 ALK Business Overview
  4. 7.1.3 ALK Allergy Immunotherapies Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ALK Allergy Immunotherapies Product Portfolio
  6. 7.1.5 ALK Recent Developments
  7. 7.2 Stallergenes
  8. 7.2.1 Stallergenes Company Information
  9. 7.2.2 Stallergenes Business Overview
  10. 7.2.3 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
  12. 7.2.5 Stallergenes Recent Developments
  13. 7.3 HAL
  14. 7.3.1 HAL Company Information
  15. 7.3.2 HAL Business Overview
  16. 7.3.3 HAL Allergy Immunotherapies Revenue and Gross Margin (2021-2026)
  17. 7.3.4 HAL Allergy Immunotherapies Product Portfolio
  18. 7.3.5 HAL Recent Developments
8 North America
  1. 8.1 North America Allergy Immunotherapies Revenue (2021-2032)
  2. 8.2 North America Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 8.2.1 North America Allergy Immunotherapies Revenue by Type (2021-2026)
  4. 8.2.2 North America Allergy Immunotherapies Revenue by Type (2027-2032)
  5. 8.3 North America Allergy Immunotherapies Revenue Share by Type (2021-2032)
  6. 8.4 North America Allergy Immunotherapies Revenue by Application (2021-2032)
  7. 8.4.1 North America Allergy Immunotherapies Revenue by Application (2021-2026)
  8. 8.4.2 North America Allergy Immunotherapies Revenue by Application (2027-2032)
  9. 8.5 North America Allergy Immunotherapies Revenue Share by Application (2021-2032)
  10. 8.6 North America Allergy Immunotherapies Revenue by Country
  11. 8.6.1 North America Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Allergy Immunotherapies Revenue by Country (2021-2026)
  13. 8.6.3 North America Allergy Immunotherapies Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Allergy Immunotherapies Revenue (2021-2032)
  2. 9.2 Europe Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 9.2.1 Europe Allergy Immunotherapies Revenue by Type (2021-2026)
  4. 9.2.2 Europe Allergy Immunotherapies Revenue by Type (2027-2032)
  5. 9.3 Europe Allergy Immunotherapies Revenue Share by Type (2021-2032)
  6. 9.4 Europe Allergy Immunotherapies Revenue by Application (2021-2032)
  7. 9.4.1 Europe Allergy Immunotherapies Revenue by Application (2021-2026)
  8. 9.4.2 Europe Allergy Immunotherapies Revenue by Application (2027-2032)
  9. 9.5 Europe Allergy Immunotherapies Revenue Share by Application (2021-2032)
  10. 9.6 Europe Allergy Immunotherapies Revenue by Country
  11. 9.6.1 Europe Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Allergy Immunotherapies Revenue by Country (2021-2026)
  13. 9.6.3 Europe Allergy Immunotherapies Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Allergy Immunotherapies Revenue (2021-2032)
  2. 10.2 China Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 10.2.1 China Allergy Immunotherapies Revenue by Type (2021-2026)
  4. 10.2.2 China Allergy Immunotherapies Revenue by Type (2027-2032)
  5. 10.3 China Allergy Immunotherapies Revenue Share by Type (2021-2032)
  6. 10.4 China Allergy Immunotherapies Revenue by Application (2021-2032)
  7. 10.4.1 China Allergy Immunotherapies Revenue by Application (2021-2026)
  8. 10.4.2 China Allergy Immunotherapies Revenue by Application (2027-2032)
  9. 10.5 China Allergy Immunotherapies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Allergy Immunotherapies Revenue (2021-2032)
  2. 11.2 Asia Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 11.2.1 Asia Allergy Immunotherapies Revenue by Type (2021-2026)
  4. 11.2.2 Asia Allergy Immunotherapies Revenue by Type (2027-2032)
  5. 11.3 Asia Allergy Immunotherapies Revenue Share by Type (2021-2032)
  6. 11.4 Asia Allergy Immunotherapies Revenue by Application (2021-2032)
  7. 11.4.1 Asia Allergy Immunotherapies Revenue by Application (2021-2026)
  8. 11.4.2 Asia Allergy Immunotherapies Revenue by Application (2027-2032)
  9. 11.5 Asia Allergy Immunotherapies Revenue Share by Application (2021-2032)
  10. 11.6 Asia Allergy Immunotherapies Revenue by Country
  11. 11.6.1 Asia Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Allergy Immunotherapies Revenue by Country (2021-2026)
  13. 11.6.3 Asia Allergy Immunotherapies Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Allergy Immunotherapies Revenue (2021-2032)
  2. 12.2 SAMEA Allergy Immunotherapies Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Allergy Immunotherapies Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Allergy Immunotherapies Revenue by Type (2027-2032)
  5. 12.3 SAMEA Allergy Immunotherapies Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Allergy Immunotherapies Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Allergy Immunotherapies Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Allergy Immunotherapies Revenue by Application (2027-2032)
  9. 12.5 SAMEA Allergy Immunotherapies Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Allergy Immunotherapies Revenue by Country
  11. 12.6.1 SAMEA Allergy Immunotherapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Allergy Immunotherapies Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Allergy Immunotherapies Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst